Contemporary Reviews in Cardiovascular Medicine The Assessment of Endothelial Function From Research Into Clinical Practice
By A. Flammer, T. Anderson, D. Celermajer, M. Creager, J. Deanfield, P. Ganz, N. Hamburg, M. Shechter, S. Taddei, J. Vita and 1 more. 2012
1,061 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/83b334a5349e293c25c6244726f75023fd7cdad8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Kautzky-Willer
- E. Gerdts
- A. Maas
- S. Oertelt-Prigione
- K. Schenck-Gustafsson
- A. Foryst-Ludwig
- Vera Regitz-Zagrosek
- Dorit Knappe-Wegner
Citations in the corpus
- Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. (2016, background): “plications and leave vascular dysfunction or coronary microvessel disease in symptomatic women underdiagnosed.(46) In 2014, the American Heart Association launched evidence-based”
- Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. (2019, unknown): “14 Importantly, non-invasive techniques have been validated against coronary endothelial function, providing the pathophysiological basis for the predictive value of these tests for CVD. 16,17”
- Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies (2021, background): “Taken together, the gold standard for clinical evaluation of endothelial function is FMD in response to acetylcholine (Goligorsky, 2006; Flammer et al., 2012).”